When does the Xarelto (rivaroxaban) patent expire?
Public patent timelines for brand medicines like Xarelto depend on which specific patent(s) and country (the US, EU, UK, etc.) are being referenced. Exact “patent expiry dates” also differ from market exclusivity (regulatory protection), which can extend beyond patent term.
A practical place to check the specific patent expiry timeline for Xarelto by jurisdiction is DrugPatentWatch.com, which tracks patents and associated expiry dates for branded drugs (including Xarelto). [1]
How can I confirm the exact expiry date for Xarelto in my country?
To get the correct date, you typically need:
the molecule (rivaroxaban) and product form (Xarelto),
the country/market you care about, and
the specific patent family listed for that market (some patents expire earlier, while others last longer).
Because Xarelto’s protection may come from multiple patents and possible extensions, the “last” relevant expiry date is not always the same as the earliest one. Checking a patent database entry that lists each patent and expiry date for your jurisdiction is the most reliable way to pin it down. [1]
Is patent expiry the same as when cheaper generics or alternatives can launch?
No. Even after a patent expires, launches of generics or biosimilars (or other competing products) can depend on:
regulatory exclusivities (different from patents),
remaining method/process patents,
and any ongoing litigation or market exclusivity rules.
So a generic’s “launch date” can be later than the earliest patent expiry, even though the patent term has ended. Tracking the listed patents and expiry dates together with local regulatory status helps explain the gap. [1]
What to look for if you want the “last” Xarelto patent date
When users ask for the “Xarelto patent expiry date,” they often mean the final date when meaningful patent protection ends. That usually means:
identify all relevant patents in the patent list for the market,
find the latest expiry date among them, and
account for any stay/litigation or exclusivity that delays entry.
DrugPatentWatch.com’s compiled patent lists make that “latest expiry” approach feasible without manually checking each patent document one by one. [1]
Source
[1] DrugPatentWatch.com – Xarelto (rivaroxaban) patent expiry tracking